EZH2 overexpression and its clinicopathologic implication in gastric carcinoma

초록

Background: Overexpression of enhancer of zeste homolog 2 (EZH2), a member of polycomb group proteins, is linked closely to various advenced and metastatic cancer. In this study, we investigated the expression of EZH2 in gastric cancer and evaluated its relatonship with the clinicopathological features and patient survival.